Indaptus Therapeutics
INDP
8 hedge funds and large institutions have $14.4M invested in Indaptus Therapeutics in 2015 Q3 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$4.69M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$3.69M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$3.6M |
| 4 |
PA
Perceptive Advisors
New York
|
+$2.05M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$788K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CAM
1
Cormorant Asset Management
Boston,
Massachusetts
| $4.48M | +$4.69M | +357 | New |
|
|
OM
2
Opaleye Management
Boston,
Massachusetts
| $3.53M | +$3.69M | +281 | New |
|
|
SM
3
Sabby Management
Miami Beach,
Florida
| $3.44M | +$3.6M | +274 | New |
|
|
PA
4
Perceptive Advisors
New York
| $1.96M | +$2.05M | +156 | New |
|
|
DCM
5
DAFNA Capital Management
Los Angeles,
California
| $756K | +$788K | +60 | New |
|
6
Jane Street
New York
| $194K | +$197K | +15 | New |
|
|
IAM
7
Ion Asset Management
Herzliya,
Israel
| $56K | +$52.5K | +4 | New |
|
8
UBS Group
Zurich,
Switzerland
| $7K | +$13.1K | +1 | New |
|
INDP Hedge Fund Activity: Q3 2015 in Review
8 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Indaptus Therapeutics (INDP) for Q3 2015, worth a combined $14.4M.
Buyers outnumbered sellers: 8 funds opened new INDP positions and 0 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $4.69M.
- 8 institutional investors held Indaptus Therapeutics (INDP) as of Q3 2015, up from 0 in Q2 2015.
- Funds reported $14.4M of Indaptus Therapeutics stock for Q3 2015.
- 8 funds opened new Indaptus Therapeutics positions in Q3 2015 and 0 closed out, a net change of +8 holders.
- The largest Indaptus Therapeutics buyer in Q3 2015 was Cormorant Asset Management, an estimated $4.69M added.
Based on aggregated 13F filings for Q3 2015.